AUC,Rank,Term_Name,Overlapping_Genes,Adjusted_P-value,Source
0.5,2,BDNF-TrkB Signaling WP3676,"NTRK2, TRPC6",0.5722397987875586,WikiPathways_2019_Human
0.5,3,Breast cancer pathway WP4262,"FGF9, IGF1, ESR2",0.6937485744083792,WikiPathways_2019_Human
0.5,1,MAPK Signaling Pathway WP382,"NTRK2, CACNB2, FGF9, MAPK8IP3",0.8928769913011705,WikiPathways_2019_Human
0.5,5,HIF1A and PPARG regulation of glycolysis WP2456,GPD1,1.0,WikiPathways_2019_Human
0.5,6,Caloric restriction and aging WP4191,IGF1,1.0,WikiPathways_2019_Human
0.5,7,Genes targeted by miRNAs in adipocytes WP1992,IGF1,1.0,WikiPathways_2019_Human
0.5,8,Disorders of Folate Metabolism and Transport WP4259,SLC46A1,1.0,WikiPathways_2019_Human
0.5,9,ERK Pathway in Huntington's Disease WP3853,NTRK2,1.0,WikiPathways_2019_Human
0.5,10,Oxysterols derived from cholesterol WP4545,ESR2,1.0,WikiPathways_2019_Human
0.5,11,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",SCARB1,1.0,WikiPathways_2019_Human
0.5,13,Extracellular vesicles in the crosstalk of cardiac cells WP4300,IGF1,1.0,WikiPathways_2019_Human
0.5,15,Nicotine Activity on Dopaminergic Neurons WP1602,KCNK9,1.0,WikiPathways_2019_Human
0.5,16,Glycerophospholipid Biosynthetic Pathway WP2533,GPD1,1.0,WikiPathways_2019_Human
0.5,4,Folate Metabolism WP176,"SCARB1, SLC46A1",1.0,WikiPathways_2019_Human
0.5,18,Triacylglyceride Synthesis WP325,GPD1,1.0,WikiPathways_2019_Human
0.5,19,Sphingolipid pathway WP1422,SPTLC2,1.0,WikiPathways_2019_Human
0.5,20,Statin Pathway WP430,SCARB1,1.0,WikiPathways_2019_Human
0.5,21,"Oligodendrocyte Specification and differentiation(including remyelination), leading to Myelin Components for CNS WP4304",IGF1,1.0,WikiPathways_2019_Human
0.5,22,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,IGF1,1.0,WikiPathways_2019_Human
0.5,23,Ovarian Infertility Genes WP34,ESR2,1.0,WikiPathways_2019_Human
0.55,3,Triacylglyceride Synthesis WP325,"LIPE, GPD1",0.8153526949077174,WikiPathways_2019_Human
0.55,7,miR-517 relationship with ARCN1 and USP1 WP3596,CDKN1A,1.0,WikiPathways_2019_Human
0.55,8,Nicotine Metabolism WP1600,CYP2A6,1.0,WikiPathways_2019_Human
0.55,9,LncRNA-mediated mechanisms of therapeutic resistance WP3672,CDKN1A,1.0,WikiPathways_2019_Human
0.55,11,Caloric restriction and aging WP4191,IGF1,1.0,WikiPathways_2019_Human
0.55,12,HIF1A and PPARG regulation of glycolysis WP2456,GPD1,1.0,WikiPathways_2019_Human
0.55,15,Methylation Pathways WP704,TPMT,1.0,WikiPathways_2019_Human
0.55,4,BDNF-TrkB Signaling WP3676,"NTRK2, TRPC6",1.0,WikiPathways_2019_Human
0.55,19,Disorders of Folate Metabolism and Transport WP4259,SLC46A1,1.0,WikiPathways_2019_Human
0.55,20,Genes targeted by miRNAs in adipocytes WP1992,IGF1,1.0,WikiPathways_2019_Human
0.55,21,Valproic acid pathway WP3871,CYP2A6,1.0,WikiPathways_2019_Human
0.55,5,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,"NLRP7, NLRP1",1.0,WikiPathways_2019_Human
0.55,23,ERK Pathway in Huntington's Disease WP3853,NTRK2,1.0,WikiPathways_2019_Human
0.55,24,Oxysterols derived from cholesterol WP4545,ESR2,1.0,WikiPathways_2019_Human
0.55,25,Fatty Acid Omega Oxidation WP206,CYP2A6,1.0,WikiPathways_2019_Human
0.55,26,GPR40 Pathway WP3958,PLCD1,1.0,WikiPathways_2019_Human
0.55,27,miRNAs involved in DNA damage response WP1545,CDKN1A,1.0,WikiPathways_2019_Human
0.55,29,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",SCARB1,1.0,WikiPathways_2019_Human
0.55,31,Drug Induction of Bile Acid Pathway WP2289,BAAT,1.0,WikiPathways_2019_Human
0.55,2,Breast cancer pathway WP4262,"CDKN1A, FGF9, IGF1, ESR2",1.0,WikiPathways_2019_Human
0.6,7,miR-517 relationship with ARCN1 and USP1 WP3596,CDKN1A,1.0,WikiPathways_2019_Human
0.6,10,Nicotine Metabolism WP1600,CYP2A6,1.0,WikiPathways_2019_Human
0.6,11,LncRNA-mediated mechanisms of therapeutic resistance WP3672,CDKN1A,1.0,WikiPathways_2019_Human
0.6,1,Triacylglyceride Synthesis WP325,"LIPE, GPD1",1.0,WikiPathways_2019_Human
0.6,12,Caloric restriction and aging WP4191,IGF1,1.0,WikiPathways_2019_Human
0.6,13,HIF1A and PPARG regulation of glycolysis WP2456,GPD1,1.0,WikiPathways_2019_Human
0.6,16,Methylation Pathways WP704,TPMT,1.0,WikiPathways_2019_Human
0.6,4,Ovarian Infertility Genes WP34,"LHCGR, ESR2",1.0,WikiPathways_2019_Human
0.6,5,BDNF-TrkB Signaling WP3676,"NTRK2, TRPC6",1.0,WikiPathways_2019_Human
0.6,19,Disorders of Folate Metabolism and Transport WP4259,SLC46A1,1.0,WikiPathways_2019_Human
0.6,20,Genes targeted by miRNAs in adipocytes WP1992,IGF1,1.0,WikiPathways_2019_Human
0.6,21,Valproic acid pathway WP3871,CYP2A6,1.0,WikiPathways_2019_Human
0.6,22,Vitamin B12 Disorders WP4271,MUT,1.0,WikiPathways_2019_Human
0.6,6,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,"NLRP7, NLRP1",1.0,WikiPathways_2019_Human
0.6,25,ERK Pathway in Huntington's Disease WP3853,NTRK2,1.0,WikiPathways_2019_Human
0.6,26,Oxysterols derived from cholesterol WP4545,ESR2,1.0,WikiPathways_2019_Human
0.6,27,Fatty Acid Omega Oxidation WP206,CYP2A6,1.0,WikiPathways_2019_Human
0.6,28,GPR40 Pathway WP3958,PLCD1,1.0,WikiPathways_2019_Human
0.6,29,miRNAs involved in DNA damage response WP1545,CDKN1A,1.0,WikiPathways_2019_Human
0.6,31,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",SCARB1,1.0,WikiPathways_2019_Human
0.65,3,Farnesoid X Receptor  Pathway WP2879,"BAAT, CYP7A1",0.8553798110319479,WikiPathways_2019_Human
0.65,9,BDNF-TrkB Signaling WP3676,"NTRK2, TRPC6",0.8835970403581778,WikiPathways_2019_Human
0.65,8,Ovarian Infertility Genes WP34,"LHCGR, ESR2",0.8855555845107572,WikiPathways_2019_Human
0.65,1,Oxysterols derived from cholesterol WP4545,"CYP7A1, ESR2",1.0,WikiPathways_2019_Human
0.65,12,miR-517 relationship with ARCN1 and USP1 WP3596,CDKN1A,1.0,WikiPathways_2019_Human
0.65,2,Drug Induction of Bile Acid Pathway WP2289,"BAAT, CYP7A1",1.0,WikiPathways_2019_Human
0.65,13,Nicotine Metabolism WP1600,CYP2A6,1.0,WikiPathways_2019_Human
0.65,14,LncRNA-mediated mechanisms of therapeutic resistance WP3672,CDKN1A,1.0,WikiPathways_2019_Human
0.65,4,Triacylglyceride Synthesis WP325,"LIPE, GPD1",1.0,WikiPathways_2019_Human
0.65,17,Caloric restriction and aging WP4191,IGF1,1.0,WikiPathways_2019_Human
0.65,18,HIF1A and PPARG regulation of glycolysis WP2456,GPD1,1.0,WikiPathways_2019_Human
0.65,20,Cytosine methylation WP3585,IDH1,1.0,WikiPathways_2019_Human
0.65,21,Methylation Pathways WP704,TPMT,1.0,WikiPathways_2019_Human
0.65,5,Statin Pathway WP430,"SCARB1, CYP7A1",1.0,WikiPathways_2019_Human
0.65,23,Liver X Receptor Pathway WP2874,CYP7A1,1.0,WikiPathways_2019_Human
0.65,28,Bile Acids synthesis and enterohepatic circulation  WP4389,CYP7A1,1.0,WikiPathways_2019_Human
0.65,29,Disorders of Folate Metabolism and Transport WP4259,SLC46A1,1.0,WikiPathways_2019_Human
0.65,30,Genes targeted by miRNAs in adipocytes WP1992,IGF1,1.0,WikiPathways_2019_Human
0.65,31,Valproic acid pathway WP3871,CYP2A6,1.0,WikiPathways_2019_Human
0.65,32,Vitamin B12 Disorders WP4271,MUT,1.0,WikiPathways_2019_Human
0.7,9,Metapathway biotransformation Phase I and II WP702,"CYP2A6, CYP26B1, TPMT, BAAT, CYP7A1",0.5830145737727983,WikiPathways_2019_Human
0.7,8,Nicotine Activity on Dopaminergic Neurons WP1602,"CHRNB2, KCNK9",0.5987506870580431,WikiPathways_2019_Human
0.7,12,Adipogenesis WP236,"LIPE, CDKN1A, CYP26B1, IGF1",0.5996206650637667,WikiPathways_2019_Human
0.7,11,Glycosylation and related congenital defects. WP4521,"DOLK, MPDU1",0.6103582004486947,WikiPathways_2019_Human
0.7,10,Triacylglyceride Synthesis WP325,"LIPE, GPD1",0.6206240714845286,WikiPathways_2019_Human
0.7,5,Drug Induction of Bile Acid Pathway WP2289,"BAAT, CYP7A1",0.6323613055047503,WikiPathways_2019_Human
0.7,6,Farnesoid X Receptor  Pathway WP2879,"BAAT, CYP7A1",0.656294895624663,WikiPathways_2019_Human
0.7,7,Oxidation by Cytochrome P450 WP43,"CYP26B1, CYP2A6, CYP7A1",0.6790345936202258,WikiPathways_2019_Human
0.7,13,Statin Pathway WP430,"SCARB1, CYP7A1",0.6858003699887345,WikiPathways_2019_Human
0.7,4,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522","SCARB1, PCSK9",0.7007942423638704,WikiPathways_2019_Human
0.7,14,Ovarian Infertility Genes WP34,"LHCGR, ESR2",0.7670091537160183,WikiPathways_2019_Human
0.7,16,Breast cancer pathway WP4262,"CDKN1A, FGF9, IGF1, ESR2",0.7813525316096587,WikiPathways_2019_Human
0.7,2,Bile Acids synthesis and enterohepatic circulation  WP4389,"SLC10A2, CYP7A1",0.7857538131686728,WikiPathways_2019_Human
0.7,15,BDNF-TrkB Signaling WP3676,"NTRK2, TRPC6",0.8020704668000784,WikiPathways_2019_Human
0.7,3,Oxysterols derived from cholesterol WP4545,"CYP7A1, ESR2",0.8215072138911587,WikiPathways_2019_Human
0.7,18,miR-517 relationship with ARCN1 and USP1 WP3596,CDKN1A,0.9433265646645422,WikiPathways_2019_Human
0.7,17,MAPK Signaling Pathway WP382,"CACNB2, NTRK2, FGF9, MAPK8IP3, DUSP6",0.9593170548773374,WikiPathways_2019_Human
0.7,21,LncRNA-mediated mechanisms of therapeutic resistance WP3672,CDKN1A,0.9667784011434174,WikiPathways_2019_Human
0.7,19,Vitamin A and Carotenoid Metabolism WP716,"SCARB1, CYP26B1",0.9769198538603511,WikiPathways_2019_Human
0.7,20,Nicotine Metabolism WP1600,CYP2A6,1.0,WikiPathways_2019_Human
0.75,1,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522","SCARB1, PCSK9, LCAT, APOA1, APOE",0.0002337652189549382,WikiPathways_2019_Human
0.75,2,Statin Pathway WP430,"SCARB1, LCAT, APOA1, APOE, CYP7A1",0.0028420256708992994,WikiPathways_2019_Human
0.75,3,Composition of Lipid Particles WP3601,"APOA1, LCAT, APOE",0.014598967293440927,WikiPathways_2019_Human
0.75,5,Primary Focal Segmental Glomerulosclerosis FSGS WP2572,"CAMK2B, MYO1E, CDKN1A, TRPC6, COL4A3",0.0927831205902902,WikiPathways_2019_Human
0.75,4,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,"NLRP12, NLRP7, NLRC4, NLRP1",0.10597460968152073,WikiPathways_2019_Human
0.75,6,Vitamin B12 Metabolism WP1533,"SCARB1, APOA1, APOE, MUT",0.1492277821729929,WikiPathways_2019_Human
0.75,7,Bile Acids synthesis and enterohepatic circulation  WP4389,"SLC10A2, CYP7A1",0.459829319784812,WikiPathways_2019_Human
0.75,8,Oxysterols derived from cholesterol WP4545,"CYP7A1, ESR2",0.6269408764279959,WikiPathways_2019_Human
0.75,10,Drug Induction of Bile Acid Pathway WP2289,"BAAT, CYP7A1",0.6407128398095231,WikiPathways_2019_Human
0.75,15,Nicotine Activity on Dopaminergic Neurons WP1602,"CHRNB2, KCNK9",0.6416205602104751,WikiPathways_2019_Human
0.75,24,Sphingolipid pathway WP1422,"COL4A3BP, SPTLC2",0.6432257615503074,WikiPathways_2019_Human
0.75,9,Adipogenesis WP236,"LIPE, FOXC2, CDKN1A, CYP26B1, IGF1",0.6466279781556064,WikiPathways_2019_Human
0.75,21,Genotoxicity pathway WP4286,"CDKN1A, HIST1H1E, PPM1D",0.650461271858077,WikiPathways_2019_Human
0.75,22,PPAR Alpha Pathway WP2878,"APOA1, CYP7A1",0.6541872611901153,WikiPathways_2019_Human
0.75,14,Human Complement System WP2806,"C3, CFHR4, APOA1, SFTPA1",0.6567775397053193,WikiPathways_2019_Human
0.75,19,TYROBP Causal Network WP3945,"C3, MAF, KCNE3",0.6615390228484989,WikiPathways_2019_Human
0.75,12,Farnesoid X Receptor  Pathway WP2879,"BAAT, CYP7A1",0.6621357253426906,WikiPathways_2019_Human
0.75,20,Glycosylation and related congenital defects. WP4521,"DOLK, MPDU1",0.6688198521727852,WikiPathways_2019_Human
0.75,23,Folate Metabolism WP176,"SCARB1, SLC46A1, APOA1",0.6689691207610706,WikiPathways_2019_Human
0.75,13,BMP Signaling Pathway in Eyelid Development WP3927,"FOXC2, MAP3K1",0.6744505867865468,WikiPathways_2019_Human
0.8,1,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522","SCARB1, LIPG, PCSK9, LCAT, APOA1, APOE",4.466307132335947e-05,WikiPathways_2019_Human
0.8,2,Statin Pathway WP430,"SCARB1, LCAT, APOA1, APOE, CYP7A1",0.018160004516553644,WikiPathways_2019_Human
0.8,3,Composition of Lipid Particles WP3601,"APOA1, LCAT, APOE",0.04591152812250612,WikiPathways_2019_Human
0.8,4,Breast cancer pathway WP4262,"CDKN1A, FGF8, FZD2, RAD51, FGF9, CSNK2B, IGF1, SOS2, ESR2",0.08256599469609414,WikiPathways_2019_Human
0.8,5,Vitamin B12 Metabolism WP1533,"SCARB1, APOA1, APOE, MUT, INS",0.09929656168333684,WikiPathways_2019_Human
0.8,8,Adipogenesis WP236,"LIPE, FOXC2, CDKN1A, CYP26B1, PTGIS, IGF1, INS",0.25159969788516384,WikiPathways_2019_Human
0.8,7,Nicotine Activity on Dopaminergic Neurons WP1602,"CHRNB2, KCNK9, CHRNA4",0.2713303045592665,WikiPathways_2019_Human
0.8,16,Cardiac Progenitor Differentiation WP2406,"NOG, IGF1, MYH6, INS",0.2724260679000773,WikiPathways_2019_Human
0.8,9,Primary Focal Segmental Glomerulosclerosis FSGS WP2572,"CAMK2B, MYO1E, CDKN1A, TRPC6, COL4A3",0.27621932357088713,WikiPathways_2019_Human
0.8,14,Mesodermal Commitment Pathway WP2857,"FOXC2, FGF8, NOG, TBX6, SMAD6, JAK2, PHF6",0.2776564120333827,WikiPathways_2019_Human
0.8,15,Calcium Regulation in the Cardiac Cell WP536,"CAMK2B, KCNJ5, PLN, GJB3, GNA11, CACNA1C, CALM1",0.2780997190712557,WikiPathways_2019_Human
0.8,12,PI3K-Akt Signaling Pathway WP4172,"NTRK2, CDKN1A, FGF8, FGF9, COL4A3, PPP2R5D, IGF1, JAK2, SOS2, EPOR, EPHA2, INS",0.28450592977044115,WikiPathways_2019_Human
0.8,11,Glycosylation and related congenital defects. WP4521,"TUSC3, DOLK, MPDU1",0.2852313655541974,WikiPathways_2019_Human
0.8,6,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,"NLRP12, NLRP7, NLRC4, NLRP1",0.29046590181507864,WikiPathways_2019_Human
0.8,17,Cardiac Hypertrophic Response WP2795,"MAP3K1, GUCA1A, IGF1, CALM1",0.29152531877847965,WikiPathways_2019_Human
0.8,13,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,"LIPE, CDKN1A, FGF8, FGF9, PPP2R5D, IGF1, JAK2, EPOR, EPHA2, RAB11B, INS",0.29503799416682086,WikiPathways_2019_Human
0.8,10,Differentiation Pathway WP2848,"FGF8, NOG, IGF1, INS",0.3076520109985479,WikiPathways_2019_Human
0.8,18,Gene regulatory network modelling somitogenesis  WP2854,"FGF8, TBX6",0.3168445856906545,WikiPathways_2019_Human
0.8,21,Signal transduction through IL1R WP4496,"IL1RN, MAP3K1, IRAK3",0.3235513767050586,WikiPathways_2019_Human
0.8,22,MAPK Signaling Pathway WP382,"CACNB2, NTRK2, MAP3K1, FGF8, FGF9, CACNA1C, MAPK8IP3, SOS2, DUSP6",0.32582956623479675,WikiPathways_2019_Human
0.85,1,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522","ABCA1, SCARB1, LIPG, PCSK9, LCAT, APOA1, APOE, LDLRAP1",4.3641581103552433e-07,WikiPathways_2019_Human
0.85,4,Dopaminergic Neurogenesis WP2855,"SOX2, NEUROD1, FGF8, OTX2, GLI2, PITX3",0.006911349248835825,WikiPathways_2019_Human
0.85,3,Common Pathways Underlying Drug Addiction WP2636,"PPP1CB, CAMK2A, CALM1, ACTG2, GRIA3, ACTG1, GRIA4",0.0076729949317689535,WikiPathways_2019_Human
0.85,2,Statin Pathway WP430,"ABCA1, SCARB1, LCAT, APOA1, APOE, CYP7A1",0.011279503897411723,WikiPathways_2019_Human
0.85,5,Mesodermal Commitment Pathway WP2857,"SOX2, SMAD2, EXT1, FOXC2, FGF8, NOG, PAX6, TBX6, SMAD6, JAK2, PHF6, KDM6A",0.017100059805182987,WikiPathways_2019_Human
0.85,6,Cardiac Progenitor Differentiation WP2406,"SOX2, NOG, TBX20, PAX6, IGF1, MYH6, INS",0.017566702349525665,WikiPathways_2019_Human
0.85,8,Epithelial to mesenchymal transition in colorectal cancer WP4239,"SMAD2, DLL4, FOXC2, FZD2, COL4A2, TUSC3, CLDN14, COL4A3, PKP1, RBPJ, SOS2, LRP6",0.02208907682366125,WikiPathways_2019_Human
0.85,9,Cori Cycle WP1946,"G6PD, PGK1, TALDO1, INS",0.02259049227532274,WikiPathways_2019_Human
0.85,7,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,"NLRP12, NLRP7, NOD2, NLRC4, RAC1, NLRP1",0.024061926521654873,WikiPathways_2019_Human
0.85,12,Vitamin B12 Metabolism WP1533,"ABCA1, SCARB1, APOA1, APOE, MUT, INS",0.04155304580535188,WikiPathways_2019_Human
0.85,11,Breast cancer pathway WP4262,"DLL4, CDKN1A, FGF8, FZD2, RAD51, FGF9, CSNK2B, IGF1, SOS2, ESR2, LRP6",0.04397239250104007,WikiPathways_2019_Human
0.85,10,Composition of Lipid Particles WP3601,"APOA1, LCAT, APOE",0.045438261392374314,WikiPathways_2019_Human
0.85,13,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,"SOX2, CHRNB2, NEUROD1, NTRK2, IL1RN, REST, CHRNA4, CTCF, ESR2, YWHAG, HSPD1",0.045836628949199924,WikiPathways_2019_Human
0.85,14,Primary Focal Segmental Glomerulosclerosis FSGS WP2572,"KIRREL3, CAMK2B, MYO1E, CDKN1A, TRPC6, COL4A3, LRP6",0.04918353102005004,WikiPathways_2019_Human
0.85,18,MAPK Signaling Pathway WP382,"NTRK2, MAP3K1, HSPB1, CACNA1C, MAPK8IP3, DUSP6, CACNA1H, CACNA1G, CDC42, CACNB2, FGF8, FGF9, RAC1, SOS2",0.054038809417803826,WikiPathways_2019_Human
0.85,15,Endoderm Differentiation WP2853,"SOX2, SMAD2, EXT1, NOG, OTX2, NAA15, PHF6, PTHLH, BPTF, GLI2",0.056822159434160725,WikiPathways_2019_Human
0.85,17,G13 Signaling Pathway WP524,"CDC42, PPP1CB, DIAPH1, RAC1, CALM1",0.05696454677656353,WikiPathways_2019_Human
0.85,16,Human Complement System WP2806,"C3, PRNP, RPS19, C9, CFHR4, CFI, APOA1, SFTPA1",0.058603748916893614,WikiPathways_2019_Human
0.85,19,Glycosylation and related congenital defects. WP4521,"TUSC3, DOLK, MAGT1, MPDU1",0.0629667859819242,WikiPathways_2019_Human
0.85,20,Calcium Regulation in the Cardiac Cell WP536,"CAMK2B, KCNJ5, PLN, GJB3, GNA11, CAMK2A, ATP2B2, CACNA1C, CALM1, YWHAG",0.06392256142005226,WikiPathways_2019_Human
0.9,1,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522","ABCA1, SCARB1, LIPG, PCSK9, LCAT, APOA1, APOE, LDLRAP1",2.1065368584106367e-05,WikiPathways_2019_Human
0.9,2,Striated Muscle Contraction Pathway WP383,"MYBPC1, MYH3, ACTC1, TPM3, TNNC1, TPM2, MYL2, MYH8, TCAP, MYH6, ACTG1",2.739793876091137e-05,WikiPathways_2019_Human
0.9,5,Epithelial to mesenchymal transition in colorectal cancer WP4239,"SMAD2, FOXC2, MAP2K1, SMAD3, FZD2, TUSC3, FZD4, RBPJ, LRP6, DLL4, ZEB1, COL4A2, CLDN14, AKT3, COL4A3, PKP1, COL4A5, CTNNB1, CLDN16, SOS2, EZH2",7.583684838129891e-05,WikiPathways_2019_Human
0.9,3,Primary Focal Segmental Glomerulosclerosis FSGS WP2572,"KIRREL3, CAMK2B, CDKN1A, CDKN1B, TRPC6, ITGB4, DNM1, LRP6, MYO1E, INF2, COL4A3, COL4A5, CTNNB1, VCL",8.007793189391517e-05,WikiPathways_2019_Human
0.9,4,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,"RYR2, ITGB4, ACTN1, ATP2A2, CACNA1C, CACNA1F, ACTB, ACTG1, CACNB2, GJA1, SGCB, CTNNB1, CACNA1S, EMD",8.535871925735247e-05,WikiPathways_2019_Human
0.9,7,Common Pathways Underlying Drug Addiction WP2636,"PPP1CB, MAP2K1, GJB1, CAMK2A, CALM1, ACTG2, ACTB, GRIA3, ACTG1, GRIA4",0.00021371165384489386,WikiPathways_2019_Human
0.9,8,Mesodermal Commitment Pathway WP2857,"SMAD2, FOXC2, SMAD3, FZD4, NOG, GATA6, PAX6, TBX6, SMAD6, PHF6, GRHL2, SOX2, EXT1, EXT2, FGF8, HNF4A, JAK2, KDM6A, CUL4B",0.0002175555472636028,WikiPathways_2019_Human
0.9,6,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,"CHRNB2, RYR2, NTRK2, IL1RN, CAV3, CHRNA4, BDNF, CTCF, ESR2, HSPD1, SOX2, NEUROD1, AR, GJA1, REST, PAH, PLP1, EP300, CTNNB1, YWHAG",0.00022480822852047498,WikiPathways_2019_Human
0.9,9,Statin Pathway WP430,"ABCA1, SCARB1, ABCG8, ABCG5, LCAT, APOA1, APOE, CYP7A1",0.000500622698604087,WikiPathways_2019_Human
0.9,15,Endoderm Differentiation WP2853,"SMAD2, SMAD3, NOG, GATA6, PHF6, GRHL2, PTHLH, GLI2, SOX2, EXT1, NKX2-1, CTNNB1, OTX2, NAA15, BPTF, EZH2, CUL4B",0.0009347598381051126,WikiPathways_2019_Human
0.9,14,MAPK Signaling Pathway WP382,"NTRK2, MAP2K1, MAP3K1, BDNF, PDGFB, HSPB1, CACNA1C, CACNA1F, MAPK8IP3, DUSP6, CACNA1H, CACNA1G, CDC42, PPP3CA, CACNB2, FGF8, FGF9, RASA1, AKT3, FAS, RAC1, CACNA1S, MAP3K7, SOS2",0.0009693672795863199,WikiPathways_2019_Human
0.9,10,PI3K-Akt Signaling Pathway WP4172,"CDKN1A, CDKN1B, LAMC3, ITGB4, PDGFB, INS, FGF8, FGF9, PPP2R1A, AKT3, RAC1, JAK2, JAK3, NTRK2, MAP2K1, VWF, BDNF, PPP2R5D, IGF1, MTOR, EPOR, COL1A1, COL4A2, COL4A3, GNB1, COL4A5, COL9A3, COL9A2, SOS2, EPHA2",0.0010263722494531654,WikiPathways_2019_Human
0.9,13,Cardiac Progenitor Differentiation WP2406,"SOX2, ACTC1, MYL2, NOG, TBX20, CXCR4, PAX6, IGF1, MYH6, INS",0.0010410157172993967,WikiPathways_2019_Human
0.9,12,Breast cancer pathway WP4262,"MAP2K1, CDKN1A, FZD2, IGF1, ESR2, MTOR, LRP6, DLL4, RAD50, FGF8, RAD51, FGF9, AKT3, CSNK2B, DVL1, CTNNB1, POLK, SOS2",0.0010506816704337917,WikiPathways_2019_Human
0.9,16,ESC Pluripotency Pathways WP3931,"MAP2K1, FZD2, FZD4, NOG, PDGFB, SMAD9, HNF1A, SMAD6, MTOR, LRP6, FGF8, FGF9, AKT3, DVL1, CTNNB1",0.0011197735116069642,WikiPathways_2019_Human
0.9,11,Focal Adhesion WP306,"MAP2K1, CAV3, VWF, LAMC3, ITGB4, ACTN1, CAV1, PDGFB, IGF1, ACTB, ACTG1, COL1A1, PPP1CB, CDC42, DIAPH1, COL4A2, MYL2, AKT3, CTNNB1, RAC1, VCL",0.001122919473607156,WikiPathways_2019_Human
0.9,17,Calcium Regulation in the Cardiac Cell WP536,"CAMK2B, RYR2, KCNJ5, CAMK2A, ATP2A2, ATP2B2, CACNA1C, GJA1, GJB1, PLN, GJA3, GJB3, GNA11, GNB1, CACNA1S, CALM1, YWHAG",0.0016757486384275345,WikiPathways_2019_Human
0.9,18,Nuclear Receptors WP170,"AR, THRA, HNF4A, ESRRB, NR2F1, NR0B1, NR2F2, ESR2",0.002100120494431647,WikiPathways_2019_Human
0.9,21,MECP2 and Associated Rett Syndrome WP3584,"REST, SIN3A, BDNF, CAMK2A, CTCF, SMC3, MTOR, CDON, TAF1, EZH2",0.0026028473496688517,WikiPathways_2019_Human
0.9,20,"Oligodendrocyte Specification and differentiation(including remyelination), leading to Myelin Components for CNS WP4304","NKX2-6, PDGFB, PLP1, SOX9, IGF1, SOX10, GLI2",0.0026554710228783958,WikiPathways_2019_Human
0.95,1,Epithelial to mesenchymal transition in colorectal cancer WP4239,"NOTCH2, NOTCH3, FOXC2, TUSC3, TWIST1, PIK3R2, RBPJ, PKD1, LRP6, DLL4, CDH1, AKT3, MAPK1, HRAS, SMAD2, DSP, WNT10B, MAP2K1, TGFB2, WNT10A, MAP2K2, SMAD3, FZD2, JAG1, FZD4, FN1, ZEB2, ZEB1, COL4A2, PIK3CA, COL4A1, CLDN14, COL4A3, PKP2, PKP1, COL4A5, CTNNB1, KRAS, CLDN16, RAF1, SOS1, TP53, SOS2, EZH2",1.5064128579316399e-12,WikiPathways_2019_Human
0.95,2,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522","ABCA1, CETP, SCARB1, MTTP, LPL, PCSK9, LCAT, APOA1, LIPC, LIPG, APOE, LDLRAP1, APOB, LDLR",2.3622418149306263e-12,WikiPathways_2019_Human
0.95,3,Breast cancer pathway WP4262,"RB1, NOTCH2, NOTCH3, CDKN1A, PTEN, PIK3R2, BRCA1, BRCA2, LRP6, DLL4, NRAS, FGF8, FGF9, AKT3, DVL1, ERBB2, MAPK1, POLK, HRAS, WNT10B, MAP2K1, WNT10A, MAP2K2, FZD2, CSNK2A1, BRAF, IGF1, ESR2, MTOR, NFKB2, RAD50, RAD51, PIK3CA, APC, CSNK2B, CTNNB1, KRAS, RAF1, SOS1, TP53, SOS2, FGFR1",3.717328803412816e-12,WikiPathways_2019_Human
0.95,4,Striated Muscle Contraction Pathway WP383,"MYBPC3, MYBPC1, TPM3, ACTN2, TNNC1, TPM2, TPM1, NEB, ACTG1, TTN, DES, MYH3, ACTC1, TNNT2, MYL2, TNNT3, MYH8, TCAP, DMD, MYH6",1.4104008768046424e-11,WikiPathways_2019_Human
0.95,6,Pathways Affected in Adenoid Cystic Carcinoma WP3651,"CEBPA, SETD2, SRCAP, KMT2C, PTEN, BRCA1, NSD1, ERBB2, HIST1H1E, EP300, HRAS, KDM6A, SMARCE1, CREBBP, MAP2K2, ATRX, SMC1A, ARID1A, IL17RD, SMARCA2, MYCN, PIK3CA, KAT6A, RAF1, TP53",6.940646753719711e-11,WikiPathways_2019_Human
0.95,5,Statin Pathway WP430,"ABCA1, CETP, SCARB1, ABCG8, ABCG5, DGAT1, MTTP, LPL, LCAT, APOA1, CYP7A1, APOA5, LIPC, APOC2, APOE, APOB, LDLR",7.392613323335534e-11,WikiPathways_2019_Human
0.95,7,Signaling Pathways in Glioblastoma WP2261,"RB1, CDKN1A, CDKN1B, PTEN, PIK3R2, BRCA1, BRCA2, CBL, NRAS, CCND2, AKT3, ERBB2, EP300, MAPK1, HRAS, PRKCG, MAP2K1, MAP2K2, CDKN2A, TSC2, BRAF, MSH6, PIK3CA, NF1, KRAS, RAF1, TP53, FGFR1",8.09781870979296e-11,WikiPathways_2019_Human
0.95,8,ESC Pluripotency Pathways WP3931,"PDGFB, PTEN, PIK3R2, LRP6, FGF8, FGF9, AKT3, DVL1, MAPK1, HRAS, JAK1, ACVR1, WNT10B, MAP2K1, WNT10A, MAP2K2, FZD2, FZD4, NOG, SMAD9, BRAF, PTPN11, HNF1A, SMAD6, MTOR, BMP4, APC, CTNNB1, RAF1, SOS1, FGF12, FGFR1, BMPR1A",2.325341203980678e-10,WikiPathways_2019_Human
0.95,9,Focal Adhesion WP306,"LAMC3, ITGB4, LAMA3, PDGFB, PTEN, PIK3R2, ACTB, MYLK, ACTG1, PPP1CB, COMP, CDC42, CCND2, AKT3, ERBB2, FLNA, MAPK1, FLNB, RAC1, FLNC, ITGB6, PAK3, HRAS, PRKCG, MAP2K1, CAV3, VWF, ACTN1, CAV1, FN1, VEGFC, BRAF, IGF1, COL1A1, DIAPH1, COL2A1, COL4A2, PIK3CA, COL4A1, MYL2, CTNNB1, RAF1, SOS1, VCL",6.703368381286316e-10,WikiPathways_2019_Human
0.95,10,Rett syndrome causing genes WP4312,"KDM5B, MEF2C, CDKL5, EIF2B2, SATB2, FOXG1, CHD4, BRAF, HDAC8, SMC1A, SMARCA2, GRIN2B, MECP2, GNAO1, SYNGAP1, TBL1XR1, SCN8A, HIVEP2, SHANK3, SCN1A",1.397551857398338e-09,WikiPathways_2019_Human
0.95,12,Synaptic signaling pathways associated with autism spectrum disorder WP4539,"CAMK2B, NTRK2, BDNF, PTEN, TSC2, UBE3A, PIK3R2, CACNA1C, GRIN2B, MTOR, NRAS, SYNGAP1, PIK3CA, DLG4, AKT3, NF1, MAPK1, KRAS, HRAS, SHANK3",2.8520714309254997e-09,WikiPathways_2019_Human
0.95,13,PI3K-Akt Signaling Pathway WP4172,"CDKN1A, CDKN1B, LAMC3, ITGB4, PTEN, BRCA1, GYS2, COMP, GHR, GYS1, CCND2, FGF8, FGF9, PPP2R1A, AKT3, RAC1, ITGB6, JAK2, HRAS, JAK3, JAK1, MAP2K1, MAP2K2, VWF, TSC2, PPP2R5D, COL2A1, COL4A2, PIK3CA, COL4A1, COL4A3, COL4A5, RAF1, SOS1, TP53, SOS2, EPHA2, CSF1R, LAMA3, PDGFB, PIK3R2, INS, NRAS, MAPK1, NTRK1, NTRK2, BDNF, FN1, VEGFC, IGF1, MTOR, EPOR, COL1A1, KITLG, GNB1, COL9A3, KRAS, COL9A2, FGF12, FGFR1",2.9457138870197935e-09,WikiPathways_2019_Human
0.95,11,Pancreatic adenocarcinoma pathway WP4263,"RB1, CDKN1A, PIK3R2, BRCA2, CDC42, AKT3, ERBB2, MAPK1, POLK, RAC1, PAK3, JAK1, SMAD2, MAP2K1, TGFB2, MAP2K2, SMAD3, STAT1, CDKN2A, BRAF, DUSP6, MTOR, RAD51, PIK3CA, KRAS, RAF1, TP53",2.9645582976381647e-09,WikiPathways_2019_Human
0.95,14,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,"SNAP25, RYR2, IL1RN, CHRNA4, MAOA, CHAT, ATP1A3, CTCF, HSPD1, SOX2, NEUROD1, MECP2, GJA1, DEAF1, EP300, ACADM, SCN5A, YWHAG, CHRNB2, KCNH2, GABRA1, NTRK2, CPT1A, MEF2C, CREBBP, CAV3, BDNF, ESR2, GCK, NFKB2, HADHB, AR, REST, KCNQ1, PAH, PLP1, CTNNB1",3.699291436264827e-09,WikiPathways_2019_Human
0.95,15,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,"DSP, RYR2, ITGB4, ACTN2, ACTN1, ATP2A2, CACNA1C, CACNA1F, ACTB, ACTG1, CACNB2, GJA1, DES, SGCA, SGCB, LMNA, PKP2, CTNNB1, DSG2, DMD, ITGB6, CACNA1S, EMD, DSC2",5.232646877852837e-09,WikiPathways_2019_Human
0.95,18,Glycosylation and related congenital defects. WP4521,"DPAGT1, ALG8, ALG9, ALG6, TUSC3, ALG2, ALG3, DOLK, MOGS, ALG12, MAGT1, GMPPB, MGAT2, MPDU1",5.248126786771438e-09,WikiPathways_2019_Human
0.95,17,MAPK Signaling Pathway WP382,"LRRK2, PDGFB, HSPB1, CACNA1C, RASGRP2, CACNA1F, CACNA1H, CACNA1G, CDC42, RPS6KA3, PPP3CA, NRAS, FGF8, FGF9, AKT3, FLNA, MAPK1, FLNB, RAC1, FLNC, CACNA1S, HRAS, MAP3K7, PRKCG, NTRK1, NTRK2, MEF2C, MAP2K1, TGFB2, MAP3K1, MAP2K2, BDNF, BRAF, MAPK8IP3, DUSP6, NFKB2, TNFRSF1A, CACNB2, RASA1, NF1, FAS, KRAS, RAF1, SOS1, TP53, FGF12, SOS2, FGFR1",5.361240675316244e-09,WikiPathways_2019_Human
0.95,16,Endometrial cancer WP4155,"CDKN1A, MAP2K1, MAP2K2, PTEN, PIK3R2, BRAF, NRAS, PIK3CA, APC, CDH1, AKT3, ERBB2, MAPK1, CTNNB1, KRAS, POLK, RAF1, SOS1, HRAS, SOS2, TP53, FGFR1",5.553742212638611e-09,WikiPathways_2019_Human
0.95,20,MET in type 1 papillary renal cell carcinoma WP4205,"CDKN1A, MAP2K1, MAP2K2, RPL11, PIK3R2, PTPN11, BRAF, CBL, CDC42, NRAS, PIK3CA, AKT3, MAPK1, KRAS, RAC1, RAF1, SOS1, PAK3, HRAS, JAK3, SOS2",7.62720650400923e-09,WikiPathways_2019_Human
0.95,19,Neural Crest Differentiation WP2064,"NOTCH2, NOTCH3, HDAC3, COL11A2, TWIST1, RBPJ, HDAC8, DLL4, FGF8, CDH1, MPZ, DVL1, SOX9, MSX1, SOX5, TFAP2A, PAX3, MITF, TBX6, SOX10, GFAP, NFKB2, BMP4, GJB1, COL2A1, PMP22, CTNNB1, FGFR1",8.003693992588253e-09,WikiPathways_2019_Human
1.0,1,PI3K-Akt Signaling Pathway WP4172,"CSF3R, IRS1, TNC, IGF1R, COMP, STK11, CCND2, FGF8, FGF9, PPP2R1A, AKT3, AKT1, PDGFRB, MAP2K1, G6PC, MAP2K2, TSC2, TSC1, COL4A2, COL4A1, COL4A4, COL4A3, COL4A5, RAF1, TP53, EPHA2, CSF1R, PDGFB, PIK3R2, PCK1, BDNF, INSR, IGF2, FN1, IGF1, NFKB1, COL1A1, COL1A2, FGF14, CDK4, GNB1, COL9A1, COL9A3, COL9A2, FGFR3, FGF12, FGFR2, FGFR1, CDKN1A, CDKN1B, LAMC3, FLT3, ITGB4, FLT4, PTEN, PIK3CD, LAMC2, BRCA1, GYS2, IKBKB, GHR, GYS1, RAC1, ITGB6, JAK2, HRAS, JAK3, JAK1, VWF, PPP2R5D, OSMR, COL2A1, PIK3CA, COL6A2, KIT, COL6A1, COL6A3, ITGA7, SOS1, SOS2, MET, TNXB, LAMA2, LAMA1, LAMA4, LAMA3, EGFR, INS, NRAS, RELN, MAPK1, NTRK1, NTRK2, LAMB3, LAMB2, VEGFC, LAMB1, MTOR, EPOR, KITLG, KRAS, TEK",2.5120867724970575e-18,WikiPathways_2019_Human
1.0,2,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,"CDKN1A, CDKN1B, CSF3R, IRS1, LAMC3, ITGB4, FLT4, ITGB2, TNC, IRS4, SLC2A1, PTEN, SLC2A2, PIK3CD, LAMC2, IGF1R, GYS2, IKBKB, COMP, GHR, LIPE, GYS1, STK11, FGF8, FGF9, PPP2R1A, AKT3, AKT1, ITGB6, JAK2, HRAS, JAK3, JAK1, PDGFRB, MAP2K1, MAP2K2, VWF, TSC2, TSC1, PPP2R5D, OSMR, COL2A1, COL4A2, PIK3CA, COL4A1, COL4A4, COL6A2, KIT, ITGA7, RAF1, SOS1, MET, EPHA2, CSF1R, TNXB, LAMA2, LAMA1, COL11A1, LAMA4, COL11A2, LAMA3, PDGFB, PIK3R2, EGFR, INS, NRAS, RELN, MAPK1, LAMB3, LAMB2, INSR, FN1, VEGFC, LAMB1, IGF1, MTOR, EPOR, RAB11B, COL1A1, COL3A1, KITLG, COL1A2, FGF14, COL5A1, COL5A2, GNB1, KRAS, TEK, FGFR3, FGF12, FGFR2, FGFR1",4.430173818799722e-17,WikiPathways_2019_Human
1.0,3,Signaling Pathways in Glioblastoma WP2261,"RB1, CDKN1A, CDKN1B, IRS1, PTEN, PIK3CD, PIK3R2, BRCA1, BRCA2, CBL, EGFR, IGF1R, NRAS, CCND2, ERBB3, AKT3, ERBB2, PLCG2, AKT1, EP300, MAPK1, HRAS, PDGFRB, PRKCG, MAP2K1, MAP2K2, CDKN2A, TSC2, TSC1, BRAF, MSH6, PIK3CA, CDK4, NF1, ATM, KRAS, RAF1, TP53, MET, FGFR2, FGFR1",7.55550996206754e-16,WikiPathways_2019_Human
1.0,4,Striated Muscle Contraction Pathway WP383,"ACTG1, TTN, TNNI2, TNNI3, DMD, MYBPC3, MYBPC1, TPM3, ACTN2, TNNC1, TPM2, TPM1, NEB, ACTN4, ACTA2, ACTA1, DES, MYH3, ACTC1, TNNT1, TNNT2, MYL2, TNNT3, MYL3, MYH8, TCAP, MYH6",1.058955324189554e-15,WikiPathways_2019_Human
1.0,5,Breast cancer pathway WP4262,"RB1, CDKN1A, FLT4, PTEN, PIK3CD, BRCA1, BRCA2, IGF1R, FGF8, FGF9, AKT3, AKT1, NBN, POLK, HRAS, MAP2K1, MAP2K2, CSNK2A1, WNT5A, AXIN2, PIK3CA, CSNK2B, KIT, RAF1, SOS1, TP53, SOS2, NOTCH2, NOTCH3, NOTCH1, LRP5, PIK3R2, EGFR, LRP6, DLL3, DLL4, NRAS, DVL1, ERBB2, DVL3, MAPK1, WNT10B, WNT10A, FZD2, BRAF, IGF1, ESR2, MTOR, NFKB2, RAD50, RAD51, APC, CDK4, CTNNB1, ATM, KRAS, FGFR1, ATR",1.5101380328362112e-15,WikiPathways_2019_Human
1.0,6,Focal Adhesion WP306,"LAMC3, ITGB4, TNC, PTEN, PIK3CD, LAMC2, ACTB, MYLK, ACTG1, IGF1R, PPP1CB, COMP, CCND2, AKT3, AKT1, RAC1, ITGB6, HRAS, PRKCG, PDGFRB, MAP2K1, VWF, ACTN1, ACTN4, COL2A1, COL4A2, PIK3CA, COL4A1, MYL2, COL4A4, COL6A2, ITGA7, RAF1, SOS1, MET, VCL, BLK, TNXB, LAMA2, LAMA1, LAMA4, LAMA3, PDGFB, PIK3R2, EGFR, CDC42, RELN, ERBB2, FLNA, MAPK1, FLNB, FLNC, PAK3, CAV3, LAMB3, LAMB2, CAV1, FN1, VEGFC, BRAF, LAMB1, IGF1, COL1A1, DIAPH1, COL1A2, COL5A2, CTNNB1",2.696773962966367e-15,WikiPathways_2019_Human
1.0,7,Epithelial to mesenchymal transition in colorectal cancer WP4239,"TUSC3, PIK3CD, RBPJ, PKD1, CDH1, AKT3, AKT1, HRAS, DSP, MAP2K1, MAP2K2, EED, WNT5A, TGFBR1, TGFBR2, ZEB2, ZEB1, COL4A2, PIK3CA, COL4A1, CLDN14, COL4A4, COL4A3, PKP2, PKP1, COL4A5, CLDN16, RAF1, SOS1, TP53, SOS2, NOTCH2, NOTCH3, FOXC2, NOTCH1, LRP5, TWIST1, PIK3R2, LRP6, DLL3, DLL4, MAPK1, SMAD2, WNT10B, TGFB2, WNT10A, SMAD4, SMAD3, FZD2, JAG1, JUP, TGFB3, FZD4, NUBPL, FN1, CTNNB1, KRAS, EZH2",6.076285011663386e-15,WikiPathways_2019_Human
1.0,9,Pathways Affected in Adenoid Cystic Carcinoma WP3651,"CEBPA, SETD2, NOTCH1, SRCAP, MAX, PRKDC, KMT2C, PTEN, BRCA1, CHEK2, NSD1, ERBB2, AKT1, HIST1H1E, EP300, HRAS, KDM6A, SMARCE1, CREBBP, MAP2K2, ATRX, SMC1A, ARID1A, IL17RD, SMARCA2, FOXP2, MYCN, PIK3CA, KANSL1, KAT6A, ATM, BCOR, RAF1, TP53",2.9495086433179416e-14,WikiPathways_2019_Human
1.0,8,Genes related to primary cilium development (based on CRISPR) WP4536,"CEP104, C2CD3, ARL6, IFT172, TTBK2, ARL13B, TCTN3, TTC21B, TCTN2, RAB23, TMEM67, INPP5E, TCTN1, TRAPPC11, BBS9, CC2D2A, BBS5, BBS4, DYNC2H1, BBS2, OFD1, EVC2, BBS1, MKKS, IFT140, WDR19, IQCE, IFT122, IFT80, RPGRIP1L, WDR35, TMEM231, MIB1, TTC8, BBS10, IFT43, EVC, IFT81, WDR60, BBS12, TMEM216, MKS1, IFT27, WDPCP",3.1145474111723346e-14,WikiPathways_2019_Human
1.0,10,Pancreatic adenocarcinoma pathway WP4263,"RB1, CDKN1A, PIK3CD, PIK3R2, BRCA2, EGFR, IKBKB, CDC42, AKT3, ERBB2, AKT1, MAPK1, POLK, RAC1, PAK3, JAK1, SMAD2, MAP2K1, TGFB2, SMAD4, MAP2K2, SMAD3, TGFB3, STAT1, CDKN2A, RIPK4, STAT3, BRAF, DUSP6, TGFBR1, NFKB1, MTOR, TGFBR2, RAD51, PIK3CA, CDK4, KRAS, RAF1, TP53, ARHGEF6",6.335185856875725e-14,WikiPathways_2019_Human
1.0,11,Integrated Breast Cancer Pathway WP1984,"RB1, BMPR2, GDI1, IRS1, PTEN, BRCA1, BRCA2, DHTKD1, STK11, CASP8, CDH1, CHEK2, AKT1, EP300, RAC1, JAK1, TSC2, TSC1, TGFBR1, TGFBR2, EDAR, MSH6, AR, MSH2, TP53, BLM, GRN, MAX, PIK3R2, EGFR, CDC42, ABL1, RHO, RAD54L, MAPK1, SMAD2, BARD1, SMAD4, STAT1, BRAF, ERAL1, SMAD6, NFKB1, MTOR, SMARCA4, RAD50, RAD51, CDK4, NF1, CTNNB1, ATM, KRAS, ATR, BMPR1A",1.181314946852378e-13,WikiPathways_2019_Human
1.0,13,ESC Pluripotency Pathways WP3931,"BMPR2, PDGFB, PTEN, LRP5, PIK3CD, PIK3R2, EGFR, LRP6, FGF8, FGF9, AKT3, DVL1, AKT1, DVL3, MAPK1, HRAS, JAK1, ACVR1, PDGFRB, WNT10B, MAP2K1, WNT10A, SMAD4, MAP2K2, FZD2, FZD4, WNT5A, NOG, STAT3, SMAD9, BRAF, PTPN11, HNF1A, SMAD6, MTOR, BMP4, FGF14, APC, CTNNB1, RAF1, SOS1, FGFR3, FGF12, FGFR2, FGFR1, BMPR1A",1.2806344311687834e-13,WikiPathways_2019_Human
1.0,12,Glycosylation and related congenital defects. WP4521,"DPAGT1, ALG8, ALG9, ALG6, TUSC3, MPI, SRD5A3, PMM2, ALG2, ALG3, ALG13, DOLK, MOGS, ALG12, MAGT1, ALG1, GMPPB, DPM1, MGAT2, MPDU1",1.3724575327333765e-13,WikiPathways_2019_Human
1.0,14,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,"RYR2, LAMA2, ITGB4, ATP2A2, CACNA1D, CACNA1C, CACNA1F, ACTB, ACTG1, GJA1, SGCD, SGCA, SGCB, LMNA, CTNNA1, DMD, ITGB6, CACNA1S, EMD, SGCG, DSP, JUP, ACTN2, CACNA2D1, ACTN1, ACTN4, CACNA2D4, CACNB2, DES, PKP2, ITGA7, CTNNB1, DSG2, DSC2",2.7266079548751976e-12,WikiPathways_2019_Human
1.0,15,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,"RET, SNAP25, RYR2, IL1RN, CTCF, SOX2, MECP2, GJA1, EP300, ACADM, SCN5A, YWHAG, CHRNB2, KCNH2, CPT1A, MEF2C, G6PC, HADHB, AR, HADHA, PRKAR1A, KCNQ1, LMX1B, AVP, DDC, CHRNA4, MAOA, CHAT, ATP1A3, GATA3, GATA2, HSPD1, NEUROD1, DEAF1, SCN3B, GABRA1, NTRK2, CREBBP, CAV3, BDNF, NFKB1, ESR2, PHOX2B, GCK, NFKB2, GRIN1, REST, TH, PAH, PLP1, CTNNB1, TCF3, CC2D1A",3.198136902887493e-12,WikiPathways_2019_Human
1.0,16,Endochondral Ossification WP474,"CDKN1C, HDAC4, THRA, IHH, GLI3, PTHLH, IGF1R, GHR, ACAN, AKT1, COL10A1, TIMP3, SOX9, SOX5, STAT5B, MEF2C, TGFB2, STAT1, PTCH1, IGF2, IGF1, RUNX2, MMP13, COL2A1, ALPL, CALM1, CALM2, FGFR3, DDR2, BMPR1A, FGFR1",4.944027724262165e-12,WikiPathways_2019_Human
1.0,17,Rett syndrome causing genes WP4312,"KDM5B, STXBP1, SATB2, FOXG1, CHD4, HDAC8, MECP2, GRIN2A, SYNGAP1, HIVEP2, SCN1A, GABBR2, MEF2C, CDKL5, EIF2B2, BRAF, SMC1A, SMARCA2, GRIN2B, SMARCA4, GNAO1, TBL1XR1, SCN8A, TCF4, SCN2A, SHANK3",1.440464985764842e-11,WikiPathways_2019_Human
1.0,18,Extracellular vesicle-mediated signaling in recipient cells WP2870,"SMAD2, TGFB2, SMAD4, SMAD3, TGFB3, WNT5A, EGFR, MTOR, TGFBR1, TGFBR2, NRAS, APC, ERBB2, AKT1, CTNNB1, KRAS, PROM1, RAF1, HRAS, MET",2.9383578300597076e-11,WikiPathways_2019_Human
1.0,19,Neural Crest Differentiation WP2064,"NOTCH2, HDAC4, NOTCH3, NOTCH1, HDAC3, COL11A2, TWIST1, RBPJ, HDAC8, DLL3, DLL4, FGF8, CDH1, MPZ, DVL1, DVL3, SOX9, MSX1, SOX5, TFAP2A, TFAP2B, PAX3, MITF, AXIN2, TBX6, SOX10, NFKB1, PHOX2B, GFAP, NFKB2, BMP4, GJB1, COL2A1, PMP22, CTNNB1, TCF4, FGFR3, FGFR2, FGFR1",2.959422957457233e-11,WikiPathways_2019_Human
1.0,20,Primary Focal Segmental Glomerulosclerosis FSGS WP2572,"CDKN1C, CAMK2B, SMARCAL1, CDKN1A, CDKN1B, NOTCH1, ITGB4, LRP5, LRP6, AKT1, PLCE1, KIRREL3, TRPC6, JAG1, LAMB2, ACTN4, DNM1, PAX2, MYO1E, INF2, NPHS1, WT1, NPHS2, COL4A4, COL4A3, MYH9, COL4A5, CTNNB1, IRF6, LMX1B, AGRN, VCL",3.17965875611424e-11,WikiPathways_2019_Human
